We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+25.57%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$25.4B
AUM Growth
+$5.37B
Cap. Flow
+$508M
Cap. Flow %
2%
Top 10 Hldgs %
19.14%
Holding
1,320
New
149
Increased
490
Reduced
420
Closed
99

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.6M
2
AMZN icon
Amazon
AMZN
+$51.1M
3
EBAY icon
eBay
EBAY
+$50.4M
4
NFLX icon
Netflix
NFLX
+$45.5M
5
RTX icon
RTX Corp
RTX
+$36.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$190M
2
MA icon
Mastercard
MA
+$48.9M
3
RTN
Raytheon Company
RTN
+$44.4M
4
PEP icon
PepsiCo
PEP
+$43.1M
5
SPGI icon
S&P Global
SPGI
+$42M

Sector Composition

Rank Sector Weight
1 Technology 28.53%
2 Healthcare 19.75%
3 Consumer Discretionary 11.03%
4 Financials 10.29%
5 Industrials 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GLRE icon
1151
Greenlight Captial
GLRE
$493M
$163K ﹤0.01%
+25,000
New +$164K
TBBK icon
1152
The Bancorp
TBBK
$2.04B
$151K ﹤0.01%
15,400
-10,800
-41% -$81.3K
ODP
1153
DELISTED
ODP
ODP
$150K ﹤0.01%
+6,390
New +$139K
GTX icon
1154
Garrett Motion
GTX
$4.78B
$144K ﹤0.01%
+26,072
New +$127K
KBAL
1155
DELISTED
Kimball International
KBAL
$142K ﹤0.01%
+12,285
New +$140K
III icon
1156
Information Services Group
III
$260M
$140K ﹤0.01%
67,400
-40,613
-38% -$87.1K
BMY.RT
1157
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$139K ﹤0.01%
38,777
+10,542
+37% +$38K
DVAX
1158
DELISTED
Dynavax Technologies
DVAX
$138K ﹤0.01%
+15,600
New +$78.8K
TIMB icon
1159
TIM SA
TIMB
$9.04B
$138K ﹤0.01%
10,660
RVI
1160
DELISTED
Retail Value Inc. Common Shares
RVI
$131K ﹤0.01%
115,688
-219,762
-66% -$249K
ESI icon
1161
Element Solutions
ESI
$7.75B
$124K ﹤0.01%
11,407
-89,593
-89% -$899K
VWTR
1162
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$120K ﹤0.01%
14,200
-7,847
-36% -$62.8K
CTT
1163
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
$113K ﹤0.01%
12,800
UGP icon
1164
Ultrapar
UGP
$7.93B
$109K ﹤0.01%
32,170
NLY icon
1165
Annaly Capital Management
NLY
$16.1B
$106K ﹤0.01%
4,022
-5,008
-55% -$124K
SGMO
1166
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$106K ﹤0.01%
+11,800
New +$109K
IDT icon
1167
IDT Corp
IDT
$1.77B
$104K ﹤0.01%
15,900
-20,984
-57% -$124K
GLUU
1168
DELISTED
Glu Mobile Inc.
GLUU
$103K ﹤0.01%
+11,100
New +$94.5K
OVV icon
1169
Ovintiv
OVV
$18.5B
$99K ﹤0.01%
10,399
VER
1170
DELISTED
VEREIT, Inc.
VER
$98K ﹤0.01%
3,058
-30,220
-91% -$841K
MCRB icon
1171
Seres Therapeutics
MCRB
$46.2M
$94K ﹤0.01%
990
-990
-50% -$86.9K
AVID
1172
DELISTED
Avid Technology Inc
AVID
$93K ﹤0.01%
12,800
LPG icon
1173
Dorian LPG
LPG
$2.43B
$92K ﹤0.01%
11,900
MTL
1174
DELISTED
Mechel PAO American Depository Shares, each representing two ordinary shares (ADSs)
MTL
$81K ﹤0.01%
+47,108
New +$82.5K
MOBL
1175
DELISTED
MobileIron, Inc.
MOBL
$78K ﹤0.01%
15,900

Similar funds

Axa's Q2 2020 Portfolio in Review

As of Q2 2020, Axa held 1,320 positions worth $25.4B, up 27% from $20B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q2 2020 filing shows 149 new, 490 increased, 420 reduced and 99 closed positions. Its largest new stake was Exelixis: 820,990 shares worth $19.5M. The largest sale was Linde, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2020 buy was Exelixis: 820,990 shares worth $19.5M.
  • Axa added most to Microsoft in Q2 2020, an estimated $82.6M increase.
  • Axa's biggest Q2 2020 reduction was Linde, cutting an estimated $190M.
  • Axa fully exited Raytheon Company in Q2 2020, selling an estimated $44.4M.
  • Axa's ten largest holdings make up 19% of its $25.4B portfolio in Q2 2020.
  • Axa opened 149 new positions and closed 99 in Q2 2020.
  • Axa's portfolio value rose 27% quarter-over-quarter to $25.4B.

Based on Axa's 13F filing for Q2 2020, filed 14 Aug 2020.